- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02553395
One Week Assessment of The Phenacite Lens
This study will investigate performance criteria over one week of daily wear to determine if the Study Test contact lens performs equivalently to the comfilcon A contact lenses in terms of subjective ratings and of visual performance.
The study test lens was not the final optical design and the study results were not used for the design validation.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
This will be double-masked, randomized, bilateral crossover study comparing the Study Test lens against the comfilcon A control lens, each worn over one week of daily wear.
The study test lens was not the final optical design and the study results were not used for the design validation.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Indiana
-
Bloomington, Indiana, United States, 47405
- Clinical Optics Research Lab (CORL) Indiana University School of Optometry, Indiana University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
A person is eligible for inclusion in the study if he/she:
- Oculo-visual examination in the last two years
- Between 18 and 35 years of age and has full legal capacity to volunteer
- Has read and understood the informed consent letter
- Is willing and able to follow instructions and maintain the appointment schedule
- Is correctable to a visual acuity of 20/25 or better (in each eye) with their habitual correction or 20/20 best corrected
- Currently wears, or has previously successfully worn, soft contact lenses between -1.00D (Diopter) and -4.50D
- Spherical Contact Lens Rx between -1.00 and -4.00 and spectacle cylinder <-0.75
- Currently spends a minimum of 4 hours a day; 5 days a week on digital devices and can replicate this time during the study period
- Is willing and able to wear the study contact lenses a minimum of 10 hours per day; 5 days a week.
Exclusion Criteria:
A person will be excluded from the study if he/she:
- Has never worn contact lenses before.
- Has any systemic disease affecting ocular health.
- Is using any systemic or topical medications that will affect ocular health.
- Has any ocular pathology or severe insufficiency of lacrimal secretion (moderate to severe dry eyes) that would affect the wearing of contact lenses.
- Has persistent, clinically significant corneal or conjunctival staining using sodium fluorescein dye.
- Has any clinically significant lid or conjunctival abnormalities, active neovascularization or any central corneal scars.
- Is aphakic.
- Has undergone corneal refractive surgery.
- Is participating in any other type of eye related clinical or research study.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Phenacite contact lens
Study Test Contact Lens
|
|
|
Active Comparator: comfilcon A contact lens
Control Contact Lens
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Binocular Distance Visual Acuity (VA) - High Illumination High Contrast
Time Frame: Baseline - After 5 minutes of lens settling
|
Binocular Distance visual acuity High Illumination High Contrast was assessed using logMAR (0.02 logMAR= 1 letter)
|
Baseline - After 5 minutes of lens settling
|
|
Binocular Distance Visual Acuity (VA) -High Illumination High Contrast
Time Frame: 1 week
|
Binocular Distance visual acuity High Illumination High Contrast was assessed using logMAR (0.02 logMAR= 1 letter)
|
1 week
|
|
Binocular Near Visual Acuity (VA) - High Illumination High Contrast
Time Frame: Baseline - after 5 minutes of lens dispense
|
Binocular Near Visual Acuity High Illumination High Contrast was assessed on logMAR VA (0.02 logMAR= 1 letter)
|
Baseline - after 5 minutes of lens dispense
|
|
Binocular Near Visual Acuity (VA) - High Illumination High Contrast
Time Frame: 1-week
|
Binocular Near Visual Acuity High Illumination High Contrast was assessed on logMAR VA (0.02 logMAR= 1 letter)
|
1-week
|
|
Binocular Distance Visual Acuity (VA) - Low Illumination High Contrast
Time Frame: Baseline (After 5 minutes of lens settling)
|
Binocular Distance Visual Acuity (VA) - Low Illumination High Contrast was assessed using logMAR VA (0.02 logMAR= 1 letter)
|
Baseline (After 5 minutes of lens settling)
|
|
Binocular Distance Visual Acuity (VA) - Low Illumination High Contrast
Time Frame: 1 week
|
Binocular Distance Visual Acuity (VA) - Low Illumination High Contrast was assessed using logMAR VA (0.02 logMAR= 1 letter)
|
1 week
|
|
Binocular Near Visual Acuity (VA) - Low Illumination High Contrast
Time Frame: Baseline (after 5 minutes of lens settling)
|
Binocular Near Visual Acuity (VA) - Low Illumination High Contrast was assessed using logMAR VA (0.02 logMAR= 1 letter)
|
Baseline (after 5 minutes of lens settling)
|
|
Binocular Near Visual Acuity (VA) - Low Illumination High Contrast
Time Frame: 1week
|
Binocular Near Visual Acuity (VA) - Low Illumination High Contrast was assessed using logMAR VA (0.02 logMAR= 1 letter)
|
1week
|
|
Subjective Ratings for Distance Quality of Vision
Time Frame: 1 week
|
Patient subjective scoring using anchors on the scale to provide a score between 0-100 for Distance Quality of Vision: (0=extremely poor vision all of the time.
Cannot function; 20= Frequently annoying vision problems; 40=Occasionally annoying vision problems; 60=occasionally noticeable but not annoying vision problems; 80=rarely noticeable vision problems; 100=excellent vision all of the time)
|
1 week
|
|
Subjective Ratings for Intermediate Quality of Vision
Time Frame: 1 week
|
Patient subjective scoring using anchors on the scale to provide a score between 0-100 for Intermediate Quality of Vision: (0=extremely poor vision all of the time.
Cannot function; 20= Frequently annoying vision problems; 40=Occasionally annoying vision problems; 60=occasionally noticeable but not annoying vision problems; 80=rarely noticeable vision problems; 100=excellent vision all of the time)
|
1 week
|
|
Subjective Ratings for Near Quality of Vision
Time Frame: 1 week
|
Patient subjective scoring using anchors on the scale to provide a score between 0-100 for Near Quality of Vision: (0=extremely poor vision all of the time.
Cannot function; 20= Frequently annoying vision problems; 40=Occasionally annoying vision problems; 60=occasionally noticeable but not annoying vision problems; 80=rarely noticeable vision problems; 100=excellent vision all of the time)
|
1 week
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Post Blink Movement -
Time Frame: Baseline (After 5 minutes of lens dispense)
|
Post blink movement was assessed by the investigator by the amount of movement (to the nearest 0.1mm) immediately after the blink (0.1mm steps)
|
Baseline (After 5 minutes of lens dispense)
|
|
Post Blink Movement
Time Frame: 1 week
|
Investigator assessment of Amount of movement (to the nearest 0.1mm) immediately after the blink (0.1mm steps)
|
1 week
|
|
Push - Up Test for Lens Tightness
Time Frame: Baseline (After 5 minutes of lens dispense)
|
Investigator assessment using Continuous Scale 0-100% (1% steps): 0%=Falls from cornea without lid support, 50%=Optimum, 100%=No movement
|
Baseline (After 5 minutes of lens dispense)
|
|
Push - Up Test for Lens Tightness
Time Frame: 1 week
|
Investigator assessment using Continuous Scale 0-100% (1% steps): 0%=Falls from cornea without lid support, 50%=Optimum, 100%=No movement
|
1 week
|
|
Lens Mobility Rating
Time Frame: Baseline (after 5 minutes of lens dispense)
|
Investigator assessment using 5 Categories in 0.50 steps: 0=Immobile - no lag in any versions, 1=Restricted - no lag in some directions but slight lag (0-0.25mm) in others, 2=Secure - slight lag (0.25-0.5mm in each version), 3=Unrestricted - freely lags in a controlled manner on all versions, but not excessive (0.5-1.0mm), 4=Very mobile - excessive lag (>1mm) on versions in all directions in 0.25 steps
|
Baseline (after 5 minutes of lens dispense)
|
|
Lens Mobility Rating
Time Frame: 1 week
|
Investigator assessment using 5 Categories in 0.50 steps: 0=Immobile - no lag in any versions, 1=Restricted - no lag in some directions but slight lag (0-0.25mm) in others, 2=Secure - slight lag (0.25-0.5mm in each version), 3=Unrestricted - freely lags in a controlled manner on all versions, but not excessive (0.5-1.0mm), 4=Very mobile - excessive lag (>1mm) on versions in all directions in 0.25 steps
|
1 week
|
|
Overall Lens Fit Acceptance
Time Frame: Baseline (After 5 minutes of lens dispense)
|
Investigator assessment using 5 Categories in 0.25 steps: 0=Can't be worn, 1=Poor - should not be dispensed although no immediate danger, 2=Fair, 3=Good, 4=Optimum in 0.25 steps
|
Baseline (After 5 minutes of lens dispense)
|
|
Overall Lens Fit Acceptance
Time Frame: 1 week
|
Investigator assessment using 5 Categories in 0.25 steps: 0=Can't be worn,, 1=Poor - should not be dispensed although no immediate danger, 2=Fair, 3=Good, 4=Optimum in 0.25 steps
|
1 week
|
|
Subjective Lens Preference - Distance Vision
Time Frame: 1 week
|
Patient subjective preference: Phenacite lens, comfilcon A or No Preference
|
1 week
|
|
Subjective Lens Preference -Overall Vision Preference
Time Frame: 1 week
|
Patient subjective preference: Phenacite test lens, comfilcon A or No Preference
|
1 week
|
|
Subjective Lens Preference - Comfort
Time Frame: 1 week
|
Patient subjective preference: Phenacite test lens, comfilcon A or No Preference
|
1 week
|
|
Subjective Overall Lens Preference
Time Frame: 1 week
|
Patient subjective overall preference: Phenacite test lens, comfilcon A or No Preference
|
1 week
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Peter Kollbaum, OD, PhD, Clinical Optics Research Lab (CORL)
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- CV-15-40
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Myopia
-
Tianjin Medical University Eye HospitalNot yet recruitingProgressive Myopia | Pediatric Myopia | Orthokeratology-related Myopia Progression
-
SightGlass Vision, Inc.RecruitingMyopia | Myopia Progression | Juvenile MyopiaUnited States
-
Shanghai Eye Disease Prevention and Treatment CenterEnrolling by invitationMyopia, Child Myopia ProgressionChina
-
Shanghai General Hospital, Shanghai Jiao Tong University...Not yet recruitingMyopia | Myopia, ProgressiveChina
-
SightGlass Vision, Inc.Recruiting
-
University of FaisalabadCompletedRefractive Errors | Myopia | Progressive MyopiaPakistan
-
Beijing Airdoc Technology Co., Ltd.Recruiting
-
Beijing Airdoc Technology Co., Ltd.The First People's Hospital of XuzhouRecruiting
-
Shanghai Eye Disease Prevention and Treatment CenterActive, not recruiting
-
Shanghai Eye Disease Prevention and Treatment CenterEnrolling by invitation
Clinical Trials on Phenacite (Test) contact lens
-
Johnson & Johnson Vision Care, Inc.Completed
-
CooperVision, Inc.Completed
-
Johnson & Johnson Vision Care, Inc.Completed
-
CooperVision, Inc.Completed
-
Johnson & Johnson Vision Care, Inc.Completed
-
CooperVision, Inc.Centre for Ocular Research & Education, CanadaCompletedMyopiaUnited States, Canada
-
CooperVision, Inc.Completed
-
Johnson & Johnson Vision Care, Inc.Completed
-
Johnson & Johnson Vision Care, Inc.CompletedLid-Parallel Conjunctival FoldsGermany
-
CooperVision, Inc.Completed